Medtech in a Minute: Medtronic's New Joint Venture, and MoreMedtech in a Minute: Medtronic's New Joint Venture, and More

Medtronic and DaVita to Launch New Kidney Device Company

Kidney patients may soon benefit from a new, independent kidney-focused medical device company that will be co-owned by Medtronic and DaVita, each with equal equity stakes, and led by an independent management team. Medtronic will contribute its renal care solutions business, including the current product portfolio (renal access, acute therapies, and chronic therapies), product pipeline, and global manufacturing R&D teams and facilities. Both companies will provide an initial investment to fund the new company and future operating capital.

Dexcom and Insulet Rumored M&A

We already expected 2022 to be a transformative year for diabetes tech with a number of key approvals pending and some smaller merger and acquisition (M&A) activity already underway. Now, a rumored deal reported by Bloomberg News suggests that Dexcom may be in M&A talks with Insulet. The rumor comes as Insulet CEO Shacey Petrovic is stepping down, and Dexcom is anticipating FDA approval for its G7 integrated continuous glucose monitoring (iCGM) sensor. Following the Bloomberg report, some medtech analysts offered early thoughts on what a Dexcom-Insulet merger might look like.

Baxter Thrives from Hillrom Acquisition

Baxter expects the Hillrom deal to contribute up to $350 million of annual pre-tax cost synergies by 2025. The firm said it expects constant currency sales growth of 4% to 5% on a compounded annual basis from 2022 through 2025. Baxter's $12.4 billion acquisition of Hillrom, which closed in December, was one of the largest medtech M&As of 2021. 

And in case you missed our last Medtech in a Minute report...

Medtech Loses a Giant; Boston Sci Co-founder Dies

Peter Nicholas, a co-founder of Boston Scientific, has died at the age of 80.

Abbott Heart Valve Data Shines at EuroPCR

The data support the use of the company's TriClip tricuspid heart valve repair device, and Navitor, Abbott's transcatheter aortic valve implantation system.

XACT Is Changing the Tone of Robotics in Healthcare

The company recently won clearance for its system to support robotic insertion and steering of probes during ablation clinical procedures.